ASI completes $5.

ASI completes $5.3 million Series A Preferred Share financing Ablative Solutions, Inc. , a privately-held business headquartered in Kalamazoo, MI with offices in Menlo Recreation area, Today that it has completed a Series A Preferred Stock funding CA announced, totaling approximately $5 . ASI is developing a different approach to Renal Denervation significantly, a fresh therapy that addresses hypertension and various other diseases related to overactive sympathetic nerve activity. Hypertension comes with an extraordinary effect on health, but it is usually a disease that is underappreciated. Tim Fischell, CMO and CEO of ASI.